<SEC-DOCUMENT>0000929638-24-001262-index.html : 20240327
<SEC-HEADER>0000929638-24-001262.hdr.sgml : 20240327
<ACCEPTANCE-DATETIME>20240327193754
ACCESSION NUMBER:		0000929638-24-001262
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240327
DATE AS OF CHANGE:		20240327
GROUP MEMBERS:		JEFF EASTON
GROUP MEMBERS:		LIND GLOBAL PARTNERS II LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NLS Pharmaceutics Ltd.
		CENTRAL INDEX KEY:			0001783036
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92065
		FILM NUMBER:		24792744

	BUSINESS ADDRESS:	
		STREET 1:		THE CIRCLE 6
		STREET 2:		8058
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH-6370
		BUSINESS PHONE:		41-41-618-80-00

	MAIL ADDRESS:	
		STREET 1:		THE CIRCLE 6
		STREET 2:		8058
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH-6370

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lind Global Fund II LP
		CENTRAL INDEX KEY:			0001871665
		ORGANIZATION NAME:           	
		IRS NUMBER:				863914253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		444 MADISON AVENUE
		STREET 2:		41ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		646-701-7428

	MAIL ADDRESS:	
		STREET 1:		444 MADISON AVENUE
		STREET 2:		41ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>sch13g.htm
<TEXT>
Document 1 - file: sch13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS
<TEXT>
Document 2 - file: exhibit99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>